Grigoriy V. Afonin

Is there a place for postoperative chemoradiotherapy in the modern treatment of non-small cell lung cancer?

Non-small cell lung cancer is the leading cause of cancer death worldwide. Despite advances in diagnostics and treatment, the prognosis for patients with locally advanced disease, particularly with mediastinal lymph node-positive disease (pN2), remains poor. Adjuvant drug therapy has become the standard of care for...